Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Former U.S. FDA Commissioner Andrew von Eschenbach On International Regulatory Collaboration: An Interview With PharmAsia News (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Former U.S. FDA Commissioner Andrew von Eschenbach spoke publicly during his reign at the agency about the need to transform FDA to respond to a globalized marketplace. In January 2008, the agency announced a new program referred to as FDA Beyond Our Borders to establish permanent offices abroad (PharmAsia News, Jan. 28, 2009). Now expecting to split his time between returning to the M.D Anderson Cancer Center in Houston and acting as a senior advisor at Greenleaf Health, a regulatory consulting firm founded by his former chief of staff Patrick Ronan, von Eschenbach spoke with PharmAsia News about his reflections on his time at FDA and the remaining challenges for the agency.
Advertisement

Related Content

Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Former FDA Commissioner Andrew von Eschenbach: An Interview With PharmAsia News (Part 2 of 2)
Advertisement
UsernamePublicRestriction

Register

SC071457

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel